SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ChemTrak
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Presti who wrote (22)10/17/1996 11:01:00 AM
From: William Presti   of 48
 
Chemtrak's distribution partner for the H. Pylori bacteria test kit, Astra (of Astra/Merck) just recently reported an approximate 40% increase in US
sales of the therapy drug Prilosec for the 1st 9 months of 1996. This is very encouraging as one would expect the positive sales report to carry over to Chemtrak's kit. I agree that CMTR is highly undervalued and is poised for a nice upturn.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News